Asset Publisher

Back From Clinical Trials to Commercialization: The Pharma/Healthcare Global Supply Chain | Clinical Trial & Cold Chain Logistics

In this special episode of QuickConversations we’re joined by a guest speaker from our parent company, Kuehne+Nagel: Robert Coyle, Senior Vice President of Pharma & Healthcare Strategy. He joins QuickSTAT’s Scott Ohanesian, Senior Vice President...

The Pharma/Healthcare global supply chain is, needless to say, a complex and extensive one. It’s also a time-critical one, with careful planning, coordination and execution that’s simply non-negotiable. The road from clinical trials to final delivery of drugs into the marketplace must be carefully followed—with a complex journey that includes scientific labs, manufacturing sites, distribution centers, and ultimately, patients.

This special episode of QuickConversations features a guest speaker from our parent company, Kuehne+Nagel: Robert Coyle, Senior Vice President of Pharma & Healthcare Strategy. He joins QuickSTAT’s Scott Ohanesian, Senior Vice President Commercial Operations, Clinical Trial Logistics, for an in-depth conversation about the pharma/healthcare global supply chain. Host Chris Riback leads this informative discussion on the full product lifecycle that centers around:
 
  • The strategic components of this vital lifeline
  • The significant planning and strategy required
  • How all of the players in the pharma/healthcare supply chain can best communicate and coordinate
  • And how to be prepared when unexpected events—including one of the magnitude of COVID-19—dictate an immediate shift in plans
Robert and Scott’s expertise covers the end-to-end planning and execution of pharma/healthcare logistics. They share that expertise in this fascinating conversation about this life-changing and life-saving global supply chain.